SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : GREAT STOCKS UNDER $15

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David K. who wrote (108)12/9/1998 9:37:00 PM
From: Bo Didley   of 126
 
ASTM has a product that EVERY HOSPITAL
in the WORLD wants:

The AastromReplicell(TM) System is an automated clinical system designed to enable hospitals to produce patient-specific cells for use in the treatment of a broad range of diseases including cancer, infectious diseases, auto-immune diseases as well as cells used in the restoration of solid tissues.

This is better than GERN...because ASTM has The AastromReplicell(TM) System to bring in huge revenues!

ASTM has a viable product.
GERN and ENMD had no viable product... and look how they gapped them.

ASTM is also going to the CANCER CONFERANCE this week.

bo

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext